Third Quarter 2025 Highlights (Compared to third quarter 2024 unless otherwise noted) Total Revenue decreased 6.7% to $73.
Product innovation and clinical science initiatives continue to flourish at AtriCure. The AtriClip Flex Mini and Cryosphere ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback